Ansøgeren anså Rapinyl for med held at kunne titreres og gentagne gange indgives effektivt og sikkert til behandling af patienter med flere episoder af gennembrudssmerter.
The Applicant considered that Rapinyl can be successfully titrated and repeatedly administered effectively and safely to treat patients with multiple episodes of breakthrough pain.